Dual Nucleosomal Double-Strand Breaks Are the Key Effectors of Curative Radiation Therapy

被引:1
作者
Brahme, Anders [1 ]
Lorat, Yvonne [2 ]
机构
[1] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden
[2] Saarland Univ, Med Ctr, Dept Radiat Protect, D-66421 Homburg, Germany
来源
BIOPHYSICA | 2023年 / 3卷 / 04期
关键词
dual double-strand breaks; dual nucleosomal DSB repair; DSB imaging; TP53 damage sensors and modification sites; light ion radiation therapy; therapy optimization; multiply damaged sites; low-dose hyper-sensitivity; low-dose apoptosis; DNA-DAMAGE; CHROMOSOME BREAKAGE; MAMMALIAN-CELLS; CRYO-EM; REPAIR; MECHANISMS; OPTIMIZATION; IRRADIATION; ELECTRONS; BYSTANDER;
D O I
10.3390/biophysica3040045
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Most ionizing radiation produces delta-rays of approximate to 1 keV that can impart MGy doses to 100 nm3 volumes of DNA. These events can produce severe dual double-strand breaks (DDSBs) on nucleosomes, particularly in dense heterochromatic DNA. This is the most common multiply damaged site, and their probabilities determine the biological effectiveness of different types of radiation. We discuss their frequency, effect on cell survival, DNA repair, and imaging by gold nanoparticle tracers and electron microscopy. This new and valuable nanometer resolution information can be used for determining the optimal tumor cure by maximizing therapeutic effects on tumors and minimizing therapeutic effects on normal tissues. The production of DDSBs makes it important to deliver a rather high dose and LET to the tumor (>2.5 Gy/Fr) and at the same time reach approximately 1.8-2.3 Gy of the lowest possible LET per fraction in TP53 intact normal tissues at risk. Therefore, their intrinsic low-dose hyper-sensitivity (LDHS)-related optimal daily fractionation window is utilized. Before full p53 activation of NHEJ and HR repair at approximate to 1/2 Gy, the low-dose apoptosis (LDA) and LDHS minimize normal tissue mutation probabilities. Ion therapy should thus ideally produce the lowest possible LET in normal tissues to avoid elevated DDSBs. Helium to boron ions can achieve this with higher-LET Bragg peaks, producing increased tumor DDSB densities. Interestingly, the highest probability of complication-free cure with boron or heavier ions requires a low LET round-up for the last 10-15 GyE, thereby steepening the dose response and further minimizing normal tissue damage. In conclusion, the new high-resolution DSB and DDSB diagnostic methods, and the new more accurate DNA-repair-based radiation biology, have been combined to increase our understanding of what is clinically important in curative radiation therapy. In fact, we must understand that we already passed the region of optimal LET and need to go back one step rather than forward, with oxygen being contemplated. As seen by the high overkill and severely high LET in the distal tumor and the increased LET to normal tissues (reminding of neutrons or neon ions), it is therefore preferable to use lithium-boron ions or combine carbon with an optimal 10-15 GyE photon, electron, or perhaps even a proton round-up, thus allowing optimized, fractionated, curative, almost complication-free treatments with photons, electrons, and light ions, introducing a real paradigm shift in curative radiation therapy with a potential 5 GyE tumor boost, 25% increase in complication-free cure and apoptotic-senescent Bragg Peak molecular light ion radiation therapy.
引用
收藏
页码:668 / 694
页数:27
相关论文
共 80 条
  • [31] Cryo-EM of NHEJ supercomplexes provides insights into DNA repair
    Chaplin, Amanda K.
    Hardwick, Steven W.
    Stavridi, Antonia Kefala
    Buehl, Christopher J.
    Goff, Noah J.
    Ropars, Virginie
    Liang, Shikang
    De Oliveira, Taiana Maia
    Chirgadze, Dimitri Y.
    Meek, Katheryn
    Charbonnier, Jean-Baptiste
    Blundell, Tom L.
    [J]. MOLECULAR CELL, 2021, 81 (16) : 3400 - +
  • [32] Enns L, 2004, MOL CANCER RES, V2, P557
  • [33] Persistence of Breakage in Specific Chromosome Bands 6 Years after Acute Exposure to Oil
    Frances, Alexandra
    Hildur, Kristin
    Albert Barbera, Joan
    Rodriguez-Trigo, Gema
    Zock, Jan-Paul
    Giraldo, Jesus
    Monyarch, Gemma
    Rodriguez-Rodriguez, Emma
    de Castro Reis, Fernanda
    Souto, Ana
    Gomez, Federico P.
    Pozo-Rodriguez, Francisco
    Templado, Cristina
    Fuster, Carme
    [J]. PLOS ONE, 2016, 11 (08):
  • [34] FRANKENBERG D, 1990, RADIAT PROT DOSIM, V31, P249
  • [35] Structure of an H1-Bound 6-Nucleosome Array Reveals an Untwisted Two-Start Chromatin Fiber Conformation
    Garcia-Saez, Isabel
    Menoni, Herve
    Boopathi, Ramachandran
    Shukla, Manu S.
    Soueidan, Lama
    Noirclerc-Savoye, Marjolaine
    Le Roy, Aline
    Skoufias, Dimitrios A.
    Bednar, Jan
    Hamiche, Ali
    Angelov, Dimitar
    Petosa, Carlo
    Dimitrov, Stefan
    [J]. MOLECULAR CELL, 2018, 72 (05) : 902 - +
  • [36] The Major DNA Repair Pathway after Both Proton and Carbon-Ion Radiation is NHEJ, but the HR Pathway is More Relevant in Carbon Ions
    Gerelchuluun, Ariungerel
    Manabe, Eri
    Ishikawa, Takaaki
    Sun, Lue
    Itoh, Kazuya
    Sakae, Takeji
    Suzuki, Kenshi
    Hirayama, Ryoichi
    Asaithamby, Aroumougame
    Chen, David J.
    Tsuboi, Koji
    [J]. RADIATION RESEARCH, 2015, 183 (03) : 345 - 356
  • [37] Radiation-induced second cancers: The impact of 3D-CRT and IMRT
    Hall, EJ
    Wuu, CS
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01): : 83 - 88
  • [38] Hamm R.N., 1976, P 5 S MICR, P1037
  • [39] The role of oxidative DNA damage in radiation induced bystander effect
    Havaki, Sophia
    Kotsinas, Athanassios
    Chronopoulos, Efstathios
    Kletsas, Dimitris
    Georgakilas, Alexandros
    Gorgoulis, Vassilis G.
    [J]. CANCER LETTERS, 2015, 356 (01) : 43 - 51
  • [40] High-resolution ROMA CGH and FISH analysis of aneuploid and diploid breast tumors
    Hicks, J.
    Muthuswamy, L.
    Krasnitz, A.
    Navin, N.
    Riggs, M.
    Grubor, V.
    Esposito, D.
    Alexander, J.
    Troge, J.
    Wigler, M.
    Maner, S.
    Lundin, P.
    Zetterberg, A.
    [J]. Molecular Approaches to Controlling Cancer, 2005, 70 : 51 - 63